Purchase Order 75N98026P00164
Award Date 3/24/26
Potential Completion Date 4/23/26
Potential Value $126K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...
- The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $55,200.00 firm fixed price purchase order to Maxcyte, Inc., a for-profit corporate entity based in Rockville, Maryland. The contract is for the procurement of an EXPERT ATX Electroporation Platform, Generation 3 with accessories, to be used for developing gene editing tools for in vivo gene therapy research. This specialized laboratory equipment supports the agency's...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $49,710 purchase order to Maxcyte, Inc. of Potomac, Maryland under a firm fixed price contract. The contract is for the delivery of a Maxcyte E-ATX Cell Processor to support the NIH/NIAID's research efforts through September 15, 2023. As the prime contractor, Maxcyte will provide its cell processing equipment without support from major subcontractors. The...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Maxcyte, Inc. The contract is for the provision of an EXPERT STX SCALABLE TRANSFECTION SYSTEM, a specialized laboratory technology, to support the agency's biomedical research mission. The contract has a ceiling value of $107,300.00 and a period of performance through September 20, 2024. Maxcyte, Inc. is a...
- This is a $120,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Maxcyte, Inc., a commercial cell engineering company, to provide specialized laboratory equipment and technologies such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services to support NIDA's...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract...
- This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Maxcyte, Inc., a small business prime contractor, on June 16, 2020 for a "Scalable Transfection System." The contract has a ceiling value of $82,100 and a completion date of September 30, 2020. Maxcyte has previously provided specialized laboratory equipment and technologies, such as cell processing systems, electroporation, and scalable transfection systems, to federal agencies including...